Nasal oxytocin for social deficits in childhood autism: a randomized controlled trial
Mark R Dadds1, Elayne MacDonald, Avril Cauchi
1School of Psychology, University of New South Wales, Sydney, NSW, 2052, Australia, m.dadds@unsw.edu.au.
Insights
Intranasal oxytocin did not improve social skills or emotion recognition in young males with autism spectrum disorder. This study suggests caution regarding broad recommendations for oxytocin as an autism intervention.
Area of Science:
- Neuroscience
- Developmental Psychology
- Pharmacology
Background:
- Oxytocin is increasingly investigated for its potential to enhance social behavior.
- Preliminary studies suggested oxytocin may be a beneficial intervention for autism spectrum disorders (ASD).
Purpose of the Study:
- To evaluate the efficacy of a 5-day intranasal oxytocin intervention in improving social interaction, emotion recognition, and repetitive behaviors in male youths with ASD.
- To assess the safety and side-effects of intranasal oxytocin in this population.
Main Methods:
- A double-blind, randomized placebo-controlled trial involving 38 male youths (7-16 years) with ASD.
- Participants received daily intranasal placebo or oxytocin (12 or 24 IU) for four consecutive days during parent-child interaction training.
- Outcomes were assessed using parent reports, clinician ratings, and independent observations.
Main Results:
- Intranasal oxytocin did not yield significant improvements in emotion recognition, social interaction skills, or general behavioral adjustment compared to placebo.
- No significant differences in repetitive behaviors or diagnostic status were observed between groups.
Conclusions:
- The benefits of intranasal oxytocin for young individuals with ASD may be limited and more specific than previously suggested.
- Caution is advised when recommending intranasal oxytocin as a broadly effective intervention for autism spectrum disorders.
Abstract:
The last two decades have witnessed a surge in research investigating the application of oxytocin as a method of enhancing social behaviour in humans. Preliminary evidence suggests oxytocin may have potential as an intervention for autism. We evaluated a 5-day 'live-in' intervention using a double-blind randomized control trial. 38 male youths (7-16 years old) with autism spectrum disorders were administered 24 or 12 international units (depending on weight) intranasal placebo or oxytocin once daily over four consecutive days. The oxytocin or placebo was administered during parent-child interaction training sessions. Parent and child behaviours were assessed using parent reports, clinician ratings, and independent observations, at multiple time points to measure side-effects; social interaction skills; repetitive behaviours; emotion recognition and diagnostic status. Compared to placebo, intranasal oxytocin did not significantly improve emotion recognition, social interaction skills, or general behavioral adjustment in male youths with autism spectrum disorders. The results show that the benefits of nasal oxytocin for young individuals with autism spectrum disorders may be more circumscribed than suggested by previous studies, and suggest caution in recommending it as an intervention that is broadly effective.
Related Concept Videos
Autism Spectrum Disorder
These core symptoms manifest differently among individuals, ranging from mild to severe. The disorder's complexity extends beyond its clinical presentation, encompassing a diverse range of biological, cognitive, and sociocultural influences.
Operant Conditioning Intervention
In operant conditioning, behaviors that are...
Modeling in Therapy
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Neurotransmitters


